Dallah Healthcare Company

SASE:4004 Rapport sur les actions

Capitalisation boursière : ر.س16.0b

La traduction de cette page est expérimentale et en cours de développement. N'hésitez pas à vos !

Dallah Healthcare Croissance future

Future contrôle des critères 2/6

Dallah Healthcare devrait augmenter ses bénéfices et son chiffre d'affaires de 13.2% et de 9.5% par an respectivement. Le BPA devrait croître de de 12.4% par an. Le rendement des capitaux propres devrait être 17.3% dans 3 ans.

Informations clés

13.2%

Taux de croissance des bénéfices

12.4%

Taux de croissance du BPA

Healthcare croissance des bénéfices14.8%
Taux de croissance des recettes9.5%
Rendement futur des capitaux propres17.3%
Couverture par les analystes

Good

Dernière mise à jour19 Aug 2024

Mises à jour récentes de la croissance future

Dallah Healthcare Company (TADAWUL:4004) Second-Quarter Results: Here's What Analysts Are Forecasting For This Year

Aug 14
Dallah Healthcare Company (TADAWUL:4004) Second-Quarter Results: Here's What Analysts Are Forecasting For This Year

Recent updates

Dallah Healthcare Company (TADAWUL:4004) Second-Quarter Results: Here's What Analysts Are Forecasting For This Year

Aug 14
Dallah Healthcare Company (TADAWUL:4004) Second-Quarter Results: Here's What Analysts Are Forecasting For This Year

The Price Is Right For Dallah Healthcare Company (TADAWUL:4004)

Jul 18
The Price Is Right For Dallah Healthcare Company (TADAWUL:4004)

Investors Will Want Dallah Healthcare's (TADAWUL:4004) Growth In ROCE To Persist

May 30
Investors Will Want Dallah Healthcare's (TADAWUL:4004) Growth In ROCE To Persist

We Ran A Stock Scan For Earnings Growth And Dallah Healthcare (TADAWUL:4004) Passed With Ease

Apr 16
We Ran A Stock Scan For Earnings Growth And Dallah Healthcare (TADAWUL:4004) Passed With Ease

What You Can Learn From Dallah Healthcare Company's (TADAWUL:4004) P/E

Mar 18
What You Can Learn From Dallah Healthcare Company's (TADAWUL:4004) P/E

Returns On Capital At Dallah Healthcare (TADAWUL:4004) Have Hit The Brakes

Feb 25
Returns On Capital At Dallah Healthcare (TADAWUL:4004) Have Hit The Brakes

Dallah Healthcare (TADAWUL:4004) Has More To Do To Multiply In Value Going Forward

Oct 30
Dallah Healthcare (TADAWUL:4004) Has More To Do To Multiply In Value Going Forward

Dallah Healthcare (TADAWUL:4004) Is Reinvesting At Lower Rates Of Return

Jul 26
Dallah Healthcare (TADAWUL:4004) Is Reinvesting At Lower Rates Of Return

Returns On Capital Signal Tricky Times Ahead For Dallah Healthcare (TADAWUL:4004)

Apr 17
Returns On Capital Signal Tricky Times Ahead For Dallah Healthcare (TADAWUL:4004)

Is Now The Time To Put Dallah Healthcare (TADAWUL:4004) On Your Watchlist?

Feb 06
Is Now The Time To Put Dallah Healthcare (TADAWUL:4004) On Your Watchlist?

Dallah Healthcare (TADAWUL:4004) Will Want To Turn Around Its Return Trends

Dec 05
Dallah Healthcare (TADAWUL:4004) Will Want To Turn Around Its Return Trends

We Ran A Stock Scan For Earnings Growth And Dallah Healthcare (TADAWUL:4004) Passed With Ease

Nov 01
We Ran A Stock Scan For Earnings Growth And Dallah Healthcare (TADAWUL:4004) Passed With Ease

Calculating The Intrinsic Value Of Dallah Healthcare Company (TADAWUL:4004)

Aug 28
Calculating The Intrinsic Value Of Dallah Healthcare Company (TADAWUL:4004)

Dallah Healthcare (TADAWUL:4004) Has Some Way To Go To Become A Multi-Bagger

Aug 12
Dallah Healthcare (TADAWUL:4004) Has Some Way To Go To Become A Multi-Bagger

Here's Why We Think Dallah Healthcare (TADAWUL:4004) Is Well Worth Watching

Jul 28
Here's Why We Think Dallah Healthcare (TADAWUL:4004) Is Well Worth Watching

Industry Analysts Just Upgraded Their Dallah Healthcare Company (TADAWUL:4004) Revenue Forecasts By 10%

May 26
Industry Analysts Just Upgraded Their Dallah Healthcare Company (TADAWUL:4004) Revenue Forecasts By 10%

Calculating The Fair Value Of Dallah Healthcare Company (TADAWUL:4004)

May 20
Calculating The Fair Value Of Dallah Healthcare Company (TADAWUL:4004)

Here's Why We Think Dallah Healthcare (TADAWUL:4004) Is Well Worth Watching

Apr 16
Here's Why We Think Dallah Healthcare (TADAWUL:4004) Is Well Worth Watching

Dallah Healthcare (TADAWUL:4004) Might Be Having Difficulty Using Its Capital Effectively

Feb 03
Dallah Healthcare (TADAWUL:4004) Might Be Having Difficulty Using Its Capital Effectively

Is Now The Time To Put Dallah Healthcare (TADAWUL:4004) On Your Watchlist?

Jan 10
Is Now The Time To Put Dallah Healthcare (TADAWUL:4004) On Your Watchlist?

Dallah Healthcare (TADAWUL:4004) Might Be Having Difficulty Using Its Capital Effectively

Oct 19
Dallah Healthcare (TADAWUL:4004) Might Be Having Difficulty Using Its Capital Effectively

Dallah Healthcare (TADAWUL:4004) Might Be Having Difficulty Using Its Capital Effectively

Jul 09
Dallah Healthcare (TADAWUL:4004) Might Be Having Difficulty Using Its Capital Effectively

Forecast: Analysts Think Dallah Healthcare Company's (TADAWUL:4004) Business Prospects Have Improved Drastically

Jun 16
Forecast: Analysts Think Dallah Healthcare Company's (TADAWUL:4004) Business Prospects Have Improved Drastically

Broker Revenue Forecasts For Dallah Healthcare Company (TADAWUL:4004) Are Surging Higher

May 02
Broker Revenue Forecasts For Dallah Healthcare Company (TADAWUL:4004) Are Surging Higher

What Kind Of Shareholders Hold The Majority In Dallah Healthcare Company's (TADAWUL:4004) Shares?

Mar 17
What Kind Of Shareholders Hold The Majority In Dallah Healthcare Company's (TADAWUL:4004) Shares?

Has Dallah Healthcare (TADAWUL:4004) Got What It Takes To Become A Multi-Bagger?

Mar 02
Has Dallah Healthcare (TADAWUL:4004) Got What It Takes To Become A Multi-Bagger?

Dallah Healthcare (TADAWUL:4004) Shareholders Booked A 45% Gain In The Last Year

Feb 15
Dallah Healthcare (TADAWUL:4004) Shareholders Booked A 45% Gain In The Last Year

Should You Buy Dallah Healthcare Company (TADAWUL:4004) For Its Dividend?

Feb 01
Should You Buy Dallah Healthcare Company (TADAWUL:4004) For Its Dividend?

Are Dallah Healthcare's (TADAWUL:4004) Statutory Earnings A Good Reflection Of Its Earnings Potential?

Jan 05
Are Dallah Healthcare's (TADAWUL:4004) Statutory Earnings A Good Reflection Of Its Earnings Potential?

Dallah Healthcare Company's (TADAWUL:4004) Intrinsic Value Is Potentially 26% Below Its Share Price

Dec 22
Dallah Healthcare Company's (TADAWUL:4004) Intrinsic Value Is Potentially 26% Below Its Share Price

Will Dallah Healthcare (TADAWUL:4004) Multiply In Value Going Forward?

Nov 20
Will Dallah Healthcare (TADAWUL:4004) Multiply In Value Going Forward?

Prévisions de croissance des bénéfices et des revenus

SASE:4004 - Estimations futures des analystes et données financières antérieures (SAR Millions )
DateRecettesLes revenusFlux de trésorerie disponibleCash from OpMoy. Nombre d'analystes
12/31/20263,9026064187498
12/31/20253,5685163326809
12/31/20243,3664803006843
6/30/20243,105444326667N/A
3/31/20243,010385415724N/A
12/31/20232,943360329626N/A
9/30/20232,831325348562N/A
6/30/20232,682270369549N/A
3/31/20232,595286333519N/A
12/31/20222,488274267442N/A
9/30/20222,370305214367N/A
6/30/20222,313311122260N/A
3/31/20222,220289166290N/A
12/31/20212,105259246362N/A
9/30/20211,935202178305N/A
6/30/20211,742206240363N/A
3/31/20211,498165110215N/A
12/31/20201,31813254183N/A
9/30/20201,25715082211N/A
6/30/20201,20712335198N/A
3/31/20201,24613133244N/A
12/31/20191,252147106307N/A
9/30/20191,22711088290N/A
6/30/20191,20611543264N/A
3/31/20191,1931195255N/A
12/31/20181,181142-51204N/A
9/30/20181,189172-158184N/A
6/30/20181,203217-131253N/A
3/31/20181,218268N/A297N/A
12/31/20171,212295N/A353N/A
9/30/20171,202284N/A457N/A
6/30/20171,180268N/A387N/A
3/31/20171,181252N/A382N/A
12/31/20161,163225N/A343N/A
9/30/20161,122228N/A244N/A
6/30/20161,073194N/A261N/A
3/31/20161,030175N/A233N/A
12/31/2015985165N/A214N/A
9/30/2015948161N/A204N/A
6/30/2015917156N/A168N/A
3/31/2015892154N/A151N/A
12/31/2014859147N/A149N/A
9/30/2014831149N/A137N/A
6/30/2014805149N/A138N/A
3/31/2014773138N/A108N/A
12/31/2013750137N/A102N/A
9/30/2013718119N/A91N/A

Prévisions de croissance des analystes

Taux de revenus par rapport au taux d'épargne: La croissance des bénéfices prévue de 4004 ( 13.2% par an) est inférieure au taux d'épargne ( 14.5% ).

Bénéfices vs marché: Les bénéfices de 4004 ( 13.2% par an) devraient croître plus rapidement que le marché SA ( 7% par an).

Croissance élevée des bénéfices: Les bénéfices de 4004 devraient augmenter, mais pas de manière significative.

Chiffre d'affaires vs marché: Le chiffre d'affaires de 4004 ( 9.5% par an) devrait croître plus rapidement que le marché SA ( 0.9% par an).

Croissance élevée des revenus: Le chiffre d'affaires de 4004 ( 9.5% par an) devrait croître plus lentement que 20% par an.

Prévisions de croissance du bénéfice par action

Rendement futur des capitaux propres

ROE futur: Le retour sur capitaux propres de 4004 devrait être faible dans 3 ans ( 17.3 %).

Découvrir les entreprises en croissance

7D

1Y

7D

1Y

7D

1Y